Mylan Institutional, Inc. recalls Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets
Recalled December 18, 2024 · FDA recall D-0134-2025 · Mylan Institutional
Hazard
Subpotent and Superpotent Drug · FDA Class II
Units
1,133 cartons
Sold at
Nationwide in the USA.
Description
Subpotent and Superpotent Drug
Product
Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-041-20
Manufacturer(s)
Mylan Institutional, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →